查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606693

去氨加压素市场：按形式、销售管道和最终用户划分 - 2025-2030 年全球预测

Desmopressin Market by Form (Injectable Solution, Nasal Spray, Tablet), Sales Channel (Offline, Online), End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年去氨加压素市场估值为12.5亿美元，预计到2024年将达到13亿美元，预计到2030年将以6.68%的复合年增长率增长至19.7亿美元。

去氨加压素是抗利尿激素增压素的合成类似物，主要用于治疗多种疾病，包括糖尿病性尿崩症、尿床和出血性疾病，如冯·维勒布兰德病和轻度形式的A型血友病了解去氨加压素的必要性在于它在保水和凝血过程中的有效作用，这使得它在需要精确液体平衡和凝血调节的医疗环境中至关重要。去氨加压素可用于医院、诊所和家庭保健，并以锭剂、注射和滴鼻剂的形式给药。最终用途主要在医疗机构内，也有可能在严格的医疗指导下用于家庭使用。根据市场洞察，主要的成长动力是中枢性糖尿病主诉等疾病的盛行率增加、对出血性疾病的认识提高以及药物传递系统的进步。人口老化和夜间遗尿发生率上升导致需求不断增加。然而，诸如低钠血症（低血钠水平）等副作用、药物核准的监管障碍以及高治疗成本等挑战限制了市场成长潜力。机会包括递送机制的持续创新，包括新型滴鼻剂和舌下片等非侵入性剂型，以及将应用扩展到新的治疗领域。利用这些机会的建议包括投资于研究和开发，以提高製剂的效率和安全性，利用战略伙伴关係进行市场扩张，以及提高新兴市场对该疾病的认识，这包括将行销工作集中在以下方面。潜在副作用和替代疗法的竞争等挑战仍然很困难，但透过改进配方和具有成本效益的解决方案来解决这些挑战可以提高竞争力。创新领域应重点关注治疗方法的最佳化以及未满足的关键字在医疗需求未满足的其他疾病的治疗中的使用。市场的本质是动态的，需要不断适应监管变化和不断变化的医疗保健需求。

主要市场统计
基准年[2023] 12.5亿美元
预测年份 [2024] 13亿美元
预测年份 [2030] 19.7亿美元
复合年增长率（%） 6.68%

市场动态：揭示快速发展的去氨加压素市场的关键市场洞察

供需的动态交互作用正在改变去氨加压素市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球糖尿病患者数量不断增加
    • 支持糖尿病意识和治疗的政府措施和计划
  • 市场限制因素
    • 与去氨加压素相关的副作用
  • 市场机会
    • 继续新配方的研发活动
    • 去氨加压素的监管核准增加
  • 市场挑战
    • 替代药物的可用性

波特的五力：驾驭去氨加压素市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解去氨加压素市场的外部影响

外部宏观环境因素在塑造去氨加压素市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解去氨加压素市场的竞争状况

对去氨加压素市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵去氨加压素市场供应商的绩效评估

FPNV定位矩阵是评估去氨加压素市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了去氨加压素市场的成功之路

去氨加压素市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球尿崩症患者数量不断增加
      • 支持糖尿病意识和治疗的政府措施和计划
    • 抑制因素
      • 与去氨加压素相关的不良反应
    • 机会
      • 新配方的持续研发活动
      • 去氨加压素的监管核准增加
    • 任务
      • 替代医学的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 去氨加压素市场：依形式

  • 注射液
  • 鼻喷剂
  • 锭剂

第七章去氨加压素市场：依销售管道

  • 离线
  • 在线的

第 8 章 去氨加压素市场：依最终用户分类

  • 居家护理
  • 医院
  • 专科诊所

第9章 美洲去氨加压素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章 亚太地区去氨加压素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲去氨加压素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AA Pharma Inc.
  • Amring Pharmaceuticals Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Apotex Inc.
  • Avadel Pharmaceuticals PLC
  • Bachem AG
  • BluePoint Laboratories
  • CSC Pharmaceuticals International
  • Dr. Reddy's Laboratories Ltd.
  • Enomark
  • Ferring Pharmaceuticals
  • Glenmark Pharmaceuticals Limited
  • Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • KVR Pharmaceuticals
  • Manus Aktteva Biopharma LLP
  • Midas Pharma GmbH
  • NorthStar Rx LLC
  • Pfizer Inc.
  • Ralington Pharma LLP
  • Saintroy Lifescience
  • Sanofi SA
  • Sava Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • VIVAN Life Sciences Pvt. Limited
Product Code: MRR-C002B1C9948C

The Desmopressin Market was valued at USD 1.25 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 6.68%, to USD 1.97 billion by 2030.

Desmopressin, a synthetic analog of the antidiuretic hormone vasopressin, is primarily used to manage various medical conditions such as diabetes insipidus, bedwetting (nocturnal enuresis), and bleeding disorders like von Willebrand's disease and mild hemophilia A. Understanding the necessity of desmopressin hinges on its effective role in water retention and coagulation processes, making it vital in medical settings that require precise fluid balance and clotting regulation. The application scope of desmopressin spans hospitals, clinics, and home healthcare settings where it is administered in forms such as tablets, injectables, and nasal sprays. The end-use is mainly within healthcare facilities, with potential home use under strict medical guidance. Market insights indicate that the primary growth drivers are increasing prevalence rates of conditions like central diabetes insipidus, heightened awareness about bleeding disorders, and advancements in drug delivery systems. Aging populations and the rising incidence of nocturnal enuresis contribute to expanding the demand. However, challenges such as side effects, including hyponatremia (low blood sodium), regulatory hurdles in drug approval, and high therapy costs limit market growth potential. Opportunities abound in the ongoing innovation of delivery mechanisms, particularly non-invasive delivery forms like novel nasal sprays or sublingual tablets, and extending applications to newer therapeutic areas. Recommendations for capitalizing on these opportunities include investing in R&D to improve formulation efficiency and safety, leveraging strategic partnerships for market expansion, and focusing marketing efforts on emerging markets where disease awareness is increasing. Limitations such as potential side effects and competition from alternative therapies remain challenging; however, addressing these through improved drug formulations and cost-effective solutions could provide a competitive edge. Areas of innovation should focus on optimizing therapeutic regimens and exploring the use of desmopressin in treating other conditions with unmet medical needs. The market's nature is dynamic, necessitating continuous adaptation to regulatory changes and evolving healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 1.25 billion
Estimated Year [2024] USD 1.30 billion
Forecast Year [2030] USD 1.97 billion
CAGR (%) 6.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Desmopressin Market

The Desmopressin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising occurrence of diabetes insipidus in patients worldwide
    • Government initiatives and programs supporting diabetes awareness & treatment
  • Market Restraints
    • Adverse effects associated with the desmopressin
  • Market Opportunities
    • Ongoing research & development activities for new formulations
    • Increasing in regulatory approvals for desmopressin
  • Market Challenges
    • Availability of alternative medicines

Porter's Five Forces: A Strategic Tool for Navigating the Desmopressin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Desmopressin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Desmopressin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Desmopressin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Desmopressin Market

A detailed market share analysis in the Desmopressin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Desmopressin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Desmopressin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Desmopressin Market

A strategic analysis of the Desmopressin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Injectable Solution, Nasal Spray, and Tablet.
  • Based on Sales Channel, market is studied across Offline and Online.
  • Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
      • 5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with the desmopressin
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & development activities for new formulations
      • 5.1.3.2. Increasing in regulatory approvals for desmopressin
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Desmopressin Market, by Form

  • 6.1. Introduction
  • 6.2. Injectable Solution
  • 6.3. Nasal Spray
  • 6.4. Tablet

7. Desmopressin Market, by Sales Channel

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. Desmopressin Market, by End-Users

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Desmopressin Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Desmopressin Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Desmopressin Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AA Pharma Inc.
  • 2. Amring Pharmaceuticals Inc.
  • 3. Antares Pharma, Inc. by Halozyme, Inc.
  • 4. Apotex Inc.
  • 5. Avadel Pharmaceuticals PLC
  • 6. Bachem AG
  • 7. BluePoint Laboratories
  • 8. CSC Pharmaceuticals International
  • 9. Dr. Reddy's Laboratories Ltd.
  • 10. Enomark
  • 11. Ferring Pharmaceuticals
  • 12. Glenmark Pharmaceuticals Limited
  • 13. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • 14. KVR Pharmaceuticals
  • 15. Manus Aktteva Biopharma LLP
  • 16. Midas Pharma GmbH
  • 17. NorthStar Rx LLC
  • 18. Pfizer Inc.
  • 19. Ralington Pharma LLP
  • 20. Saintroy Lifescience
  • 21. Sanofi S.A.
  • 22. Sava Healthcare Limited
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

  • FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
  • FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DESMOPRESSIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DESMOPRESSIN MARKET DYNAMICS
  • TABLE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023